Bitsch A - Search Results

1

Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.

Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P. Braun N, et al. Among authors: bitsch a. Neurosci Lett. 1996 Sep 6;215(2):75-8. Neurosci Lett. 1996. PMID: 8887999

2

Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosis.

Bitsch A, da Costa C, Bunkowski S, Weber F, Rieckmann P, Brück W. Bitsch A, et al. Acta Neuropathol. 1998 Apr;95(4):373-7. doi: 10.1007/s004010050813. Acta Neuropathol. 1998. PMID: 9560015

3

Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients.

Bahner D, Klucke C, Kitze B, Elitok E, Bogumil T, Dressel A, Tumani H, Weber F, Poser S, Bitsch A. Bahner D, et al. Among authors: bitsch a. Neurosci Lett. 2002 Jun 28;326(2):125-8. doi: 10.1016/s0304-3940(02)00311-7. Neurosci Lett. 2002. PMID: 12057844

4

Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.

Hackstein H, Bitsch A, Bohnert A, Hofmann H, Weber F, Ohly A, Linington C, Mäurer M, Poser S, Rieckmann P, Bein G. Hackstein H, et al. Among authors: bitsch a. J Neuroimmunol. 2001 Feb 15;113(2):240-8. doi: 10.1016/s0165-5728(00)00455-0. J Neuroimmunol. 2001. PMID: 11164908

5

Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis.

Rieckmann P, Weber F, Günther A, Martin S, Bitsch A, Broocks A, Kitze B, Weber T, Börner T, Poser S. Rieckmann P, et al. Among authors: bitsch a. J Neuroimmunol. 1996 Feb;64(2):193-200. doi: 10.1016/0165-5728(95)00176-x. J Neuroimmunol. 1996. PMID: 8632062 Clinical Trial.

6

Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.

Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P. Weber F, et al. Among authors: bitsch a. Ann Neurol. 1998 Jul;44(1):27-34. doi: 10.1002/ana.410440109. Ann Neurol. 1998. PMID: 9667590 Clinical Trial.

7

Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.

Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F. Dressel A, et al. Among authors: bitsch a. Acta Neurol Scand. 2006 Dec;114(6):368-73. doi: 10.1111/j.1600-0404.2006.00700.x. Acta Neurol Scand. 2006. PMID: 17083335 Clinical Trial.

8

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b.

Brettschneider J, Ecker D, Bitsch A, Bahner D, Bogumil T, Dressel A, Elitok E, Kitze B, Poser S, Weber F, Tumani H. Brettschneider J, et al. Among authors: bitsch a. J Neuroimmunol. 2002 Dec;133(1-2):193-7. doi: 10.1016/s0165-5728(02)00353-3. J Neuroimmunol. 2002. PMID: 12446022

9

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.

Yushchenko M, Mäder M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F. Yushchenko M, et al. Among authors: bitsch a. J Neurol. 2003 Oct;250(10):1224-8. doi: 10.1007/s00415-003-0191-4. J Neurol. 2003. PMID: 14586607 Clinical Trial.

10

Acute inflammatory CNS disease after MDMA ('ecstasy').

Bitsch A, Thiel A, Rieckmann P, Prange H. Bitsch A, et al. Eur Neurol. 1996;36(5):328-9. doi: 10.1159/000117286. Eur Neurol. 1996. PMID: 8864721 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters